Irish Independent – Open Orphan signs ‘significant’ revenue generating contract

by Ellie Donnelly Open Orphan, a Europe-focused pharma services company specialising in rare disease and so-called orphan drugs, has signed a contract with a German-based research-driven pharmaceutical company. Open Orphan said the contract guarantees “significant” annual income, with work under the deal to commence this month. This contract will see Venn Life Sciences, part of […]

Open Orphan #ORPH – Result of General Meeting

Open Orphan is pleased to announce that at the Company’s General Meeting held earlier today in relation to the Company’s proposed merger with hVIVO plc and the Proposed Placing, all of the Resolutions put to the meeting were duly passed. The Board is excited by the growth potential of the Enlarged Group following completion of […]

Open Orphan #ORPH – Pre-Admission Announcement for Euronext Growth Markets

Pre-Admission Announcement Euronext Growth Schedule 1 Announcement to be made by the Applicant prior to admission in accordance with the Euronext Growth Markets Rule Book All Applicants must complete the following Company name   Open Orphan plc (“Open Orphan” or the “Company”, and together with its subsidiaries the “Group”)   Company registered address and if different, […]

Open Orphan #ORPH – New 3 Year Contract with major Pharmaceutical Company

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce the signing of a new 3-year contract with a tier 1 German pharmaceutical company which is one of Europe’s top research-driven pharmaceutical companies. The contract guarantees significant annual revenue with work under the contract to commence this month. This contract sees Venn Life Sciences […]

Open Orphan #ORPH – hVIVO #HVO offer now unconditional as to acceptances

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF ANY SUCH JURISDICTION 31 December 2019 Recommended All Equity Offer for HVIVO PLC (“HVIVO”) to merge with OPEN ORPHAN PLC (“OPEN ORPHAN”) First Closing […]

Open Orphan #ORPH – New Contract with SFA Therapeutics

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce the signing of a contract with SFA Therapeutics, a biopharmaceutical company based in Pennsylvania, USA (“SFA Therapeutics”). This contract sees Venn Life Sciences (“Venn”), part of Open Orphan plc, provide SFA Therapeutics with assistance in the filing of a European Medicines Agency […]

Andrew Hore Quoted Micro 16 December 2019

NEX EXCHANGE Capital for Colleagues (CFCP) is investing in new portfolio company The Security Awareness Group Ltd (TSAG), which was established to acquire an existing business that has been trading for more than two decades. It provides training to ensure than employees are aware of cyber security and potential for human error. The £405,000 investment […]